Search
for
Sort by
Research 961–990 of 1000+
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Therapeutic maintenance effect of finasteride 1 mg every other month regimen in androgenetic alopecia and study on the difference in response to finasteride treatment: A prospective cohort study
- Current and future pharmacotherapy for alopecia areata
- Roles of tumor suppressors in regulating tumor-associated inflammation
- Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
- Under Development JAK Inhibitors for Dermatologic Diseases
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Therapeutic update on alopecia areata: a critical review of standard and emerging targeted therapies
- Treatment of alopecia areata with JAK inhibitors
- Pharmacological Role and Clinical Applications of 5α-Reductase Inhibitors-Review Article for Pharmacists and Healthcare Professionals
- Differential association between cumulative dose of 5α-reductase inhibitors and mortality
- 44182 Treatment with Oral Janus Kinase Inhibitors in Adults Patients with Alopecia Areata: A Systematic Review and Meta-Analysis
- Repurposing of drugs as novel influenza inhibitors from clinical gene expression infection signatures
- Cutaneous Lupus Erythematosus
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- THERAPEUTIC HOTLINE: Genetic variations in the androgen receptor gene and finasteride response in women with androgenetic alopecia mediated by epigenetics
- Therapeutic use of caffeine in dermatology: A literature review
- 046 Analysing the mechanistic basis of Ritlecitinib’s therapeutic effects in Alopecia Areata
- Janus kinase inhibitors: An innovative treatment for alopecia areata
- Wound Healing: A Cellular Perspective
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Targeting Superficial or Nodular Basal Cell Carcinoma with Topically Formulated Small Molecule Inhibitor of Smoothened